ID
30969
Description
Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Keywords
Versions (4)
- 7/8/18 7/8/18 -
- 7/8/18 7/8/18 -
- 7/21/18 7/21/18 -
- 8/18/18 8/18/18 -
Copyright Holder
see clinicaltrials.gov
Uploaded on
July 8, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593
Disease Staging Baseline
- StudyEvent: ODM
Description
Bone Marrow Biopsy
Alias
- UMLS CUI-1
- C0005954
Description
Bone Marrow Biopsy
Data type
text
Alias
- UMLS CUI [1]
- C0005954
Description
Date of Biopsy
Data type
date
Alias
- UMLS CUI [1,1]
- C0005558
- UMLS CUI [1,2]
- C0011008
Description
Marrow cellularity
Data type
text
Alias
- UMLS CUI [1]
- C1561532
Description
Tumor involvement
Data type
text
Measurement units
- %
Alias
- UMLS CUI [1]
- C1517677
Description
Dimension
Data type
text
Alias
- UMLS CUI [1]
- C0439534
Similar models
Disease Staging Baseline
- StudyEvent: ODM
C1274040 (UMLS CUI-2)
C0043299 (UMLS CUI-3)
C1274040 (UMLS CUI-4)
C0205161 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])